RVL Pharmaceuticals (RVLP) Q1 2023 Earnings

11MayConfirmed
Aug 22
Q3 2022
Q4 2022
Q1 2023
-0.21
-0.16
-0.1
-0.05

Details

Expected EPS
-0.12
Actual EPS
-0.12
Surprise EPS
0
Surprise Percent
+0%

Description

RVL Pharmaceuticals (RVLP) has reported earnings of -0.12 per share for Q1 2023.

0 Comments

Share your thoughts